Back

Prevention of cardiotoxicity.

28 May 2019 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: Clinical approach to cardio-oncological patient Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Kalliopi Keramida

Agios Savvas General Oncology Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Early detection of cardio-toxicity: the role of imaging.
Doctor T. Lopez Fernandez (Madrid, ES)
Slides Video
Presentation thumbnail
Early detection of cardio-toxicity: the role of biomarkers.
Doctor D. Cardinale (Milan, IT)
Slides Video
Presentation thumbnail
Medical Interventions.
Professor R. De Boer (Rotterdam, NL)
Presentation thumbnail
How to start a cardio-oncology service.
Doctor A. Lyon (London, GB)
Slides Video

Access the full session

Session thumbnail
Clinical approach to cardio-oncological patient

The Event

Event poster

Heart Failure 2019

28 May 2019 09:06 CET
You may be interested in
thumbnail
Congress Session
Recent perspectives in cardio-oncology
17 May 2025
thumbnail
Congress Presentation
Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.
21 May 2023
thumbnail
Congress Presentation
The most fear: how to avoid and manage proarrhythmia and toxicity?
30 March 2025
thumbnail
Congress Presentation
Identifying a cardioprotective agent using human quadricellular cardiovascular organoids for modelling chemotherapy-induced cardiomyopathy.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources